As you may already know, you don’t need a vaccine to get through COVID without any consequences!
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
Dr. Pierre Kory is a founding member of Front Line Covid-19 Critical Care Alliance (FLCCC). He has testified before the U.S. Senate Homeland Security Committee on the effectiveness of ivermectin.
Dr. Kory spent most of his career at the Beth Israel Medical Center in Manhattan, New York, where he helped run the intensive care unit. He also had a busy outpatient practice.
About six years ago, he was recruited to the St. Luke’s Aurora Medical Center in Milwaukee, Wisconsin, where he led the critical care service. “When COVID hit, I was in a leadership position,” he says. “I resigned, because of the way they were handling the pandemic.”
St. luke’s offered only supportive care, so Dr. Kory refused to remain in a leadership position under those circumstances.
“I knew there was a variety of treatments that we could use yet we were using nothing,” he says. Doctors were even told to not use anticoagulants, even though blood clotting was “through the roof” in many patients. “You could draw blood and actually see the blood clotting very quickly in the tubes,” he says.
“Since those early days, the disease seems to have changed considerably. We don’t see the high rates of blood clotting anymore, for example, which is good news.
But for some reason, from the very start, “they were literally telling us that we needed randomized controlled trials to do anything,” Kory says, and to this day, health authorities are refusing to acknowledge any treatment protocol outside of the incredibly dangerous experimental drug remdesivir, and the experimental COVID jabs.
“People were dying, yet all of my ideas were getting shouted down. My superiors were showing up to my clinical meetings and getting me to stand down, because I was entertaining the idea that we should do this, that and the other thing, and they didn’t want anything to be done.
And so, I said, ‘I’m done.’ I resigned mid-April 2020. I then went to New York for five weeks and ran my old ICU in New York.”
This is remarkable, because when you’re an expert in a field, “you’re actually responsible to share your insight and expertise,” Kory says. “Yet they were very unhappy that I was doing that.”
Seven weeks later, Kory was vindicated when the British Recovery trial results came out, showing the benefits of corticosteroids. Since then, steroids have become part of standard of care in the hospital phase.
“Steroids are an effective tool for reducing inflammation in general, but they appear particularly important for advanced COVID infection. I had a close friend who contracted a very serious case of COVID-19 and kept worsening despite taking everything I suggested.”
He knew Dr. Peter McCullough, so he texted him and was told to add prednisone and aspirin to his current regimen. As soon as he took the prednisone, he started getting better.
“Importantly, the evidence shows that when used early, during mild infection, corticosteroids do more harm than good. But once you are entering into moderate illness, as soon as you start to see lung dysfunction or the need for oxygen, steroids are critical and are clearly lifesaving.”
The point is – steroids must be used at the correct time.
Anticoagulants as a treatment
Anticoagulants can be an important component in these cases.
“What I do with coagulation is, I generally follow the D dimer on admission. D dimer is a marker of endothelial injury and clotting. In patients with normal D dimers, I’ll just do routine prophylaxis doses. If it’s moderately elevated, I do moderate [doses] and if it’s severely elevated, I’ll do full dose anticoagulants,” Kory explains.
“We have used NAC in different disease models over the years. It’s a standard treatment for acetaminophen overdose, but not for pulmonary fibrosis. In pulmonary medicine, of which I’m an expert, we had decades where we studied NAC for that. None of those studies panned out. In sepsis, it didn’t really pan out.
And so, for severe disease, we think it’s an effective drug and it’s a good antioxidant. I think it does have anticoagulation [effects], but our opinion is that it’s generally weak. So, for the hospital phase, we think it’s too weak.”
The Doctor explained further his experience, when trying to ake the hospital to give all patients Vitamin C intravenous.
“You should’ve seen the resistance I got. At one point, I was the director of the main ICU at the University of Wisconsin and the data was so overwhelming, I said, ‘Hey, guys, can’t we just start a protocol where we just give everybody on admission IV vitamin C? What’s the downside?’
Everyone started talking about kidney stones and all of this nonsense, and we have so much data to show that doesn’t happen in acute illness, or in IV formulations … I feel like I live in a cartoon of medicine, because every time I discuss something with someone, they just don’t believe anything works. Because if it worked, they would be doing it. It’s bizarre.”
Last but not least – the usage of Ivermectin?
Ivermectin is a potent antiviral. “That’s been demonstrated for 10 years now in the lab on a number of viruses,” he says. “They’ve shown that it interrupts replication of Zika, Dengue, West Nile, even HIV. And then the clinical studies are just overwhelming.” He continues:
“Can I just take one minute to say that if anyone wants to call ivermectin a controversial medicine, I just want to call out it is absolutely not controversial.
It is a medicine that is buried in corruption, and the corruption is in the suppressing of its efficacy. There are immense powers that do not want the efficacy of that drug to be known because, if it is known and becomes standard of care, it will obliterate the market for a number of novel pharmaceutical products.
When you look at the actions taken against ivermectin, it can only be understood that it’s threatening something big and powerful, because boy has it been attacked [even though it’s been used in] 64 controlled trials, almost every single one of them showing benefit, many of them large benefits.
Yet they distort it to make it seem like it’s controversial. It’s absurd. We know it works. We know it from in vitro, in vivo animal studies, and case series.”
One of the first case series, from the Dominican Republic, was published in June 2020. They treated 3,300 consecutive emergency room COVID patients with ivermectin. Of those, only 16 went on to be hospitalized and one died. That’s pretty profound, considering these were severely ill individuals.
Importantly though, there is a dose-response relationship to the viral load. The Delta variant has been shown to produce viral loads that are 250 times higher than Alpha, and as Delta became predominant, breakthrough cases in the prevention protocol started happening.
“I’m one of them. I got COVID while I was taking it weekly,” Kory says. “Now we’re doing it twice weekly. Is it the right dose? We’re not sure. But we’re seeing much fewer breakthroughs now on a higher dose. Could it be higher? Maybe. But, but we know it works as prevention.”
Higher doses of ivermectin are also used for treatment of Delta. In more advanced stages, the drug is useful thanks to its anti-inflammatory properties. Contrary to many other drugs, ivermectin is beneficial in all stages of the infection.